Page last updated: 2024-12-05
dioxathion
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
dioxathion: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6531 |
| CHEMBL ID | 2106286 |
| CHEBI ID | 81364 |
| SCHEMBL ID | 15999 |
| MeSH ID | M0046047 |
Synonyms (79)
| Synonym |
|---|
| AC-528 , |
| phosphorodithioic acid, s,s'-1,4-dioxane-2,3-diyl o,o,o',o'-tetraethyl ester |
| phosphorodithioic acid, s,s'-p-dioxane-2,3-diyl o,o,o',o'-tetraethyl ester |
| 78-34-2 |
| s,s'-1,4-dioxane-2,3-diyl o,o,o',o'-tetraethyl bis(dithiophosphate) |
| dioxathion |
| ccris 270 |
| 1,4-dioxan-2,3-diyl o,o,o',o'-tetraethyl di(phosphoromithioate) |
| ent 22,897 |
| 2,3-p-dioxan-s,s'-bis(o,o-diaethyldithiophosphat) [german] |
| einecs 201-107-7 |
| s,s'-1,4-dioxane-2,3-diyl bis(o,o-diethyl phosphorodithioate) |
| hercules ac528 |
| ac 528 |
| 2,3-p-dioxane s,s-bis(o,o-diethylphosphorodithioate) |
| 1,4-dioxan-2,3-diyl o,o,o',o'-tetraethyl di(phosphorodithioate) |
| dioxane phosphate |
| 1,4-dioxan-2,3-diyl bis(o,o-diethylphosphorothiolothionate) |
| s,s'-p-dioxane-2,3-diyl bis(o,o-diethyl phosphorodithioate) |
| navadel |
| s,s'-(p-dioxane-2,3-diyl)bis(o,o-diethylphosphorodithioate) |
| caswell no. 393 |
| hsdb 1599 |
| deltic |
| p-dioxane-2,3-diyl ethyl phosphorodithioate |
| bis(dithiophosphate de o,o-diethyle) de s,s'-(1,4-dioxanne-2,3-diyle) [french] |
| s,s'-(1,4-dioxane-2,3-diyl) o,o,o',o'-tetraethyl di(phosphorodithioate) |
| 1,4-dioxan-2,3-diyl bis(o,o-diethyl phosphorothiolothionate) |
| s,s'-(1,4-dioxane-2,3-diyl) o,o,o',o'-tetraethyl bis(phosphorodithioate) |
| dioxation |
| delnav |
| ai3-22897 |
| hercules 528 |
| p-dioxane-2,3-dithiol, s,s-diester with o,o-diethyl phosphorodithioate |
| 2,3-bis(diethoxyphosphinothioylthio)-1,4-dioxane |
| delnatex |
| 1,4-dioxan-2,3-diyl-bis(o,o-diaethyl-dithiophosphat) [german] |
| dioxationum [inn-latin] |
| 1,4-diossan-2,3-diyl-bis(o,o-dietil-ditiofosfato) [italian] |
| dioxathion [ansi:bsi:iso] |
| co-nav |
| 2,3-p-dioxandithiol s,s-bis(o,o-diethyl phosphorodithioate) |
| 1,4-dioxan-2,3-diyl s,s-di(o,o-diethyl phosphorodithioate) |
| kavadel |
| 1,4-dioxaan-2,3-diyl-bis(o,o-diethyl-dithiofosfaat) [dutch] |
| delanov |
| dioxation [inn] |
| 1,4-diossan-2,3-diil-bis(o,o-dietil-ditiofosfato) [italian] |
| 2,3-p-dioxanedithiol s,s-bis(o,o-diethyl phosphorodithioate) |
| nci-c00395 |
| epa pesticide chemical code 037801 |
| C17877 |
| chebi:81364 , |
| CHEMBL2106286 |
| 2,3-p-dioxan-s,s'-bis(o,o-diaethyldithiophosphat) |
| 1,4-diossan-2,3-diyl-bis(o,o-dietil-ditiofosfato) |
| j2df82ja7n , |
| 1,4-dioxan-2,3-diyl-bis(o,o-diaethyl-dithiophosphat) |
| dioxationum |
| dioxation [inn:ban] |
| bis(dithiophosphate de o,o-diethyle) de s,s'-(1,4-dioxanne-2,3-diyle) |
| unii-j2df82ja7n |
| 1,4-dioxaan-2,3-diyl-bis(o,o-diethyl-dithiofosfaat) |
| 1,4-diossan-2,3-diil-bis(o,o-dietil-ditiofosfato) |
| dioxation [mart.] |
| dioxation [hsdb] |
| dioxathion [iso] |
| dioxathion [mi] |
| (3-diethoxyphosphinothioylsulfanyl-1,4-dioxan-2-yl)sulfanyl-diethoxy-sulfanylidene-phosphorane |
| SCHEMBL15999 |
| 1,4-dioxan-2,3-diyl bis(o,o-diethyl phosphorodithioate) |
| s,s'-1,4-dioxane-2,3-diyl o,o,o',o'-tetraethyl bis(dithiophosphate) # |
| 2,3-p-dioxane s,s'-bis(o,o-diethyl phosphorodithioate) |
| ent 22897 |
| DTXSID9020534 |
| s,s'-1,4-dioxane-2,3-diyl o,o,o',o'-tetraethyl diphosphorodithioate |
| Q2779034 |
| dioxathion 100 microg/ml in acetonitrile |
| (3-diethoxyphosphinothioylsulfanyl-1,4-dioxan-2-yl)sulfanyl-diethoxy-sulfanylidene-lambda5-phosphane |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response relationship for 3 populations showed random heterogeneity, while systematic deviations from the linear probit lines were observed for the other 3 populations." | ( Fitting the Gompertz function to dose-response data of larval tick populations. Spickett, AM; van Ark, H, 1990) | 0.28 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
| Class | Description |
|---|---|
| dioxanes | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (16)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 14 (87.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 23.03
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.03) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (5.88%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (94.12%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||